COUP-TFII-driven venular reprogramming promotes the recruitment of both endogenous antitumor T cells and adoptively transferred tumor antigen-specific T cells, thereby inhibiting tumor growth and amplifying the efficacy of immunotherapies. Here, NR2F2 is linked to neoplasm.